WallStreetZenWallStreetZen

NASDAQ: RLYB
Rallybio Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for RLYB

Based on 5 analysts offering 12 month price targets for Rallybio Corp.
Min Forecast
$1.50-9.09%
Avg Forecast
$8.90+439.39%
Max Forecast
$15.00+809.09%

Should I buy or sell RLYB stock?

Based on 5 analysts offering ratings for Rallybio Corp.
Buy
Strong Buy
0 analysts 0%
Buy
4 analysts 80%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RLYB stock forecasts and price targets.

RLYB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-19
lockedlocked$00.00+00.00%2024-04-11
lockedlocked$00.00+00.00%2024-03-13
lockedlocked$00.00+00.00%2024-02-07
lockedlocked$00.00+00.00%2023-12-21

1 of 1

Forecast return on equity

Is RLYB forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is RLYB forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

RLYB revenue forecast

What is RLYB's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$8.3M
Avg 2 year Forecast
$67.5M
Avg 3 year Forecast
$210.0M

RLYB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RLYB$1.65$8.90+439.39%Buy
ALGS$0.82N/AN/A
IKNA$1.31$9.50+625.19%Buy
CLGN$5.36$11.00+105.22%Buy
EQ$1.81$5.00+176.24%Buy
View Top Biotech Stocks

Rallybio Stock Forecast FAQ

Is Rallybio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: RLYB) stock is to Buy RLYB stock.

Out of 5 analysts, 0 (0%) are recommending RLYB as a Strong Buy, 4 (80%) are recommending RLYB as a Buy, 1 (20%) are recommending RLYB as a Hold, 0 (0%) are recommending RLYB as a Sell, and 0 (0%) are recommending RLYB as a Strong Sell.

If you're new to stock investing, here's how to buy Rallybio stock.

What is RLYB's revenue growth forecast for 2027-2029?

(NASDAQ: RLYB) Rallybio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Rallybio's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast RLYB's revenue for 2027 to be $314,217,471, with the lowest RLYB revenue forecast at $314,217,471, and the highest RLYB revenue forecast at $314,217,471. On average, 1 Wall Street analysts forecast RLYB's revenue for 2028 to be $2,552,686,095, with the lowest RLYB revenue forecast at $2,552,686,095, and the highest RLYB revenue forecast at $2,552,686,095.

In 2029, RLYB is forecast to generate $7,940,891,820 in revenue, with the lowest revenue forecast at $7,940,891,820 and the highest revenue forecast at $7,940,891,820.

What is RLYB's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: RLYB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is RLYB's Price Target?

According to 5 Wall Street analysts that have issued a 1 year RLYB price target, the average RLYB price target is $8.90, with the highest RLYB stock price forecast at $15.00 and the lowest RLYB stock price forecast at $1.50.

On average, Wall Street analysts predict that Rallybio's share price could reach $8.90 by Apr 19, 2025. The average Rallybio stock price prediction forecasts a potential upside of 439.39% from the current RLYB share price of $1.65.

What is RLYB's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: RLYB) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.